Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;72(8):e31819.
doi: 10.1002/pbc.31819. Epub 2025 May 26.

Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High-Income Country: A 15-Year Population-Based Overview

Emily R Schwartz  1 , Kim Klein  1   2   3 , Birgit I Lissenberg-Witte  4 , Tom F W Wolfs  2 , Valérie de Haas  1   3 , Bianca Goemans  3 , Natasja Dors  3   5 , Marry M van den Heuvel-Eibrink  3 , Rutger R G Knops  3 , Wim J E Tissing  3   6 , Birgitta A Versluys  3 , C Michel Zwaan  3   7 , Raphaële R L van Litsenburg  1   3 , Gertjan J L Kaspers  1   3
Affiliations

Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High-Income Country: A 15-Year Population-Based Overview

Emily R Schwartz et al. Pediatr Blood Cancer. 2025 Aug.

Abstract

Introduction: Infection causes significant morbidity and mortality in pediatric acute myeloid leukemia (pAML). This study describes the incidence and risk factors of bloodstream infection (BSI) and invasive fungal infection (IFI) in pAML.

Methods: A retrospective chart review was performed of patients treated according to the ANLL-97/AML-12 (N = 116), AML-15 (N = 60), or DB AML-01 (N = 67) protocols between 1998 and 2014. Cumulative incidence was analyzed for infectious outcomes (any BSI, viridans group streptococci [VGS-BSI], Gram-negative rod [GNR-BSI], IFI). Risk factors were analyzed in multivariable models. Recurrent event analyses were performed to evaluate whether previous infection(s) were related to subsequent infection.

Results: The cumulative incidence of any BSI was 78%, VGS-BSI 35%, GNR-BSI 15%, and IFI 11% through Day 150. Incidence of GNR-BSI decreased over time; AML-15 hazard ratio ([HR] 0.37, 95% confidence interval [CI]: 0.14-0.98, p = 0.045) and DB AML-01 (HR 0.42, 95% CI: 0.18-0.97, p = 0.042) compared to ANLL-97/AML-12. White blood cell counts ≥20 × 109/L at diagnosis and older age were associated with lower infection risk. Recurrent event analyses showed a higher risk of subsequent BSI for patients who had two or more prior BSIs.

Conclusion: Despite efforts to improve supportive care in pAML, only GNR-BSI cumulative incidence declined over time. Future studies should continue working toward decreasing the incidence of infection while maintaining treatment efficacy.

Keywords: children; infection; leukemia; morbidity; oncology.

PubMed Disclaimer

References

    1. T. Lehrnbecher, D. Varwig, J. Kaiser, D. Reinhardt, T. Klingebiel, and U. Creutzig, “Infectious Complications in Pediatric Acute Myeloid Leukemia: Analysis of the Prospective Multi‐Institutional Clinical Trial AML‐BFM 93,” Leukemia 18, no. 1 (2004): 72–77.
    1. A. M. J. Reedijk, K. Klein, J. W. W. Coebergh, et al., “Improved Survival for Children and Young Adolescents With Acute Myeloid Leukemia: A Dutch Study on Incidence, Survival and Mortality,” Leukemia 33, no. 6 (2019): 1349–1359.
    1. G. J. Kaspers and C. M. Zwaan, “Pediatric Acute Myeloid Leukemia: Towards High‐Quality Cure of all Patients,” Haematologica 92, no. 11 (2007): 1519–1532.
    1. K. Klein, V. de Haas, and G. J. L. Kaspers, “Clinical Challenges in De Novo Pediatric Acute Myeloid Leukemia,” Expert Review of Anticancer Therapy 18, no. 3 (2018): 277–293.
    1. U. Creutzig, M. Zimmermann, D. Reinhardt, M. Dworzak, J. Stary, and T. Lehrnbecher, “Early Deaths and Treatment‐Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML‐BFM 93 and AML‐BFM 98,” Journal of Clinical Oncology 22, no. 21 (2004): 4384–4393.

MeSH terms

LinkOut - more resources